Resveratrol suppresses 4-hydroxyestradiol-induced transformation of human breast epithelial cells by blocking IκB kinaseβ-NF-κB signalling

References

• Russo J, Hasan Lareef M, Balogh G, Guo S, Russo IH. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem Mol Biol 2003;87:1–25.
   PubMed Web of Science ®Google Scholar
• Belous AR, Hachey DL, Dawling S, Roodi N, Parl FF. Cytochrome P450 1B1-mediated estrogen metabolism results in estrogen-deoxyribonucleoside adduct formation. Cancer Res 2007;67:812–817.
   PubMed Web of Science ®Google Scholar
• Rogan EG, Badawi AF, Devanesan PD, Meza JL, Edney JA, West WW, . Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer. Carcinogenesis 2003;24:697–702.
   PubMed Web of Science ®Google Scholar
• Gaikwad NW, Yang L, Muti P, Meza JL, Pruthi S, Ingle JN, . The molecular etiology of breast cancer: evidence from biomarkers of risk. Int J Cancer 2008;122:1949–1957.
   PubMed Web of Science ®Google Scholar
• Liehr JG, Fang WF, Sirbasku DA, Ari-Ulubelen A. Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem 1986;24:353–356.
   PubMedGoogle Scholar
• Newbold RR, Liehr JG. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 2000;60:235–237.
   PubMed Web of Science ®Google Scholar
• Park SA, Na HK, Kim EH, Cha YN, Surh YJ. 4-hydroxyestradiol induces anchorage-independent growth of human mammary epithelial cells via activation of IkappaB kinase: potential role of reactive oxygen species. Cancer Res 2009;69:2416–2424.
   PubMed Web of Science ®Google Scholar
• Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, . Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218–220.
   PubMed Web of Science ®Google Scholar
• Lu KT, Chiou RY, Chen LG, Chen MH, Tseng WT, Hsieh HT, . Neuroprotective effects of resveratrol on cerebral ischemia-induced neuron loss mediated by free radical scavenging and cerebral blood flow elevation. J Agr Food Chem 2006;54:3126–3131.
   PubMed Web of Science ®Google Scholar
• Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK, . Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem Biophys Res Commun 2003;309:1017–1026.
   PubMed Web of Science ®Google Scholar
• Sun AY, Simonyi A, Sun GY. The “French Paradox” and beyond: neuroprotective effects of polyphenols. Free Radic Biol Med 2002;32:314–318.
   PubMed Web of Science ®Google Scholar
• Chanvitayapongs S, Draczynska-Lusiak B, Sun AY. Amelioration of oxidative stress by antioxidants and resveratrol in PC12 cells. Neuroreport 1997;8:1499–1502.
   PubMed Web of Science ®Google Scholar
• Chen ZH, Hurh YJ, Na HK, Kim JH, Chun YJ, Kim DH, . Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells. Carcinogenesis 2004;25:2005–2013.
   PubMed Web of Science ®Google Scholar
• Chen ZH, Na HK, Hurh YJ, Surh YJ. 4-Hydroxyestradiol induces oxidative stress and apoptosis in human mammary epithelial cells: possible protection by NF-kappaB and ERK/MAPK. Toxicol Appl Pharmacol 2005;208:46–56.
   PubMedGoogle Scholar
• Bharti AC, Donato N, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 2003;171:3863–3871.
   PubMed Web of Science ®Google Scholar
• Sporn MB, Suh N. Chemoprevention: an essential approach to controlling cancer. Nat Rev Cancer 2002;2:537–543.
   PubMed Web of Science ®Google Scholar
• Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 2003;3:768–780.
   PubMed Web of Science ®Google Scholar
• Pervaiz S. Resveratrol—from the bottle to the bedside? Leuk Lymphoma 2001;40:491–498.
   PubMed Web of Science ®Google Scholar
• Lu F, Zahid M, Wang C, Saeed M, Cavalieri EL, Rogan EG. Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells. Cancer Prev Res (Phila) 2008;1:135–145.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Bueso-Ramos C, Aggarwal BB. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 2002;62:4945–4954.
   PubMed Web of Science ®Google Scholar
• Kundu JK, Shin YK, Kim SH, Surh YJ. Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity. Carcinogenesis 2006;27:1465–1474.
   PubMed Web of Science ®Google Scholar
• Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 1999;274: 30353–30356.
   PubMed Web of Science ®Google Scholar
• Yang F, Tang E, Guan K, Wang CY. IKK beta plays an essential role in the phosphorylation of RelA/p65 on serine 536 induced by lipopolysaccharide. J Immunol 2003;170: 5630–5635.
   PubMed Web of Science ®Google Scholar
• Gustin JA, Ozes ON, Akca H, Pincheira R, Mayo LD, Li Q, . Cell type-specific expression of the IkappaB kinases determines the significance of phosphatidylinositol 3-kinase/Akt signaling to NF-kappa B activation. J Biol Chem 2004;279: 1615–1620.
   PubMedGoogle Scholar
• Vandermoere F, El Yazidi-Belkoura I, Adriaenssens E, Lemoine J, Hondermarck H. The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-kappaB activation induced via interaction between Akt and IkappaB kinase-beta in breast cancer cells. Oncogene 2005;24:5482–5491.
   PubMed Web of Science ®Google Scholar
• Chen CY, Jang JH, Li MM, Surh YJ. Resveratrol upregulates heme oxyganase-1 expression via activation of NF-E2-related factor 2 in PC12 cells. Biochem Biophys Res commun 2005;331:993–1000.
   PubMed Web of Science ®Google Scholar
• Ristimaki A, Sivula A, Lundin J, Lundin M, Salminen T, Haglund C, . Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 2002;62: 632–635.
   PubMed Web of Science ®Google Scholar
• Costa C, Soares R, Reis-Filho JS, Leitao D, Amendoeira I, Schmitt FC. Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer. J Clin Pathol 2002;55:429–434.
   PubMed Web of Science ®Google Scholar